# Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

> **NCT00506922** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 150 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** Pentostatin
- **DRUG:** Tacrolimus
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00506922
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506922, "Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00506922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*